Viruses (May 2022)

Non-B, Non-C Hepatocellular Carcinoma in an HBV- and HCV-Endemic Area: A Community-Based Prospective Longitudinal Study

  • Te-Sheng Chang,
  • Nien-Tzu Hsu,
  • Shu-Chuan Chen,
  • I-Lin Hsu,
  • Mei-Hsuan Lee,
  • Sheng-Nan Lu

DOI
https://doi.org/10.3390/v14050984
Journal volume & issue
Vol. 14, no. 5
p. 984

Abstract

Read online

A large community cohort of adults who participated in a health screening program from 2003 to 2013 were prospectively analyzed for the risk factors of non-B, non-C (NBNC) hepatocellular carcinoma (HCC). The serostatus of hepatitis B and C of 52,642 participants was linked to the mortality and cancer registration data of the Health and Welfare Data Science Center, Ministry of Health and Welfare, Taiwan. During a median follow-up of 6 years, 35 of the 43,545 participants who were negative for both HBsAg and anti-HCV antibody developed HCC. Multivariate Cox regression analysis revealed that old age (hazard ratio, 95% CI: 1.058, 1.019–1.098, p = 0.003); male sex (2.446, 1.200–4.985, p = 0.014); high aspartate aminotransferase levels (6.816, 2.945–15.779, p p p = 0.006); and alpha-fetoprotein ≥15 ng/mL (143.938, 43.094–480.760, p 150 mg/dL was associated with a decreased risk of HCC (0.216, 0.074–0.625, p = 0.005). This prospective community-based study provided insights into the potential HCC risk factors which may shed some light in HCC prevention and screening.

Keywords